Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nanosonics Limited ( (AU:NAN) ) just unveiled an update.
UBS Group AG and its related bodies have become substantial holders in Nanosonics Limited, acquiring a 5.01% voting power as of July 21, 2025. This acquisition involves various UBS entities exercising control over a significant number of ordinary shares, potentially impacting Nanosonics’ shareholder dynamics and signaling confidence in the company’s market position.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products that address the need for effective disinfection technologies in medical environments.
Average Trading Volume: 803,369
Technical Sentiment Signal: Sell
Current Market Cap: A$1.16B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.